Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Wiseman

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
BMC Cancer|October 29, 2021
Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activityMark S Williams, Naseer J Basma, Fabio M R Amaral, et al.
International Journal of Surgical Pathology|July 2, 2020
E-Cadherin Expression in Blastic Plasmacytoid Dendritic Cell Neoplasms: An Unrecognized Finding and Potential Diagnostic PitfallPatrick Shenjere, Richard Chasty, Anshuman Chaturvedi, et al.
Ebiomedicine|August 9, 2020
Chronic myelomonocytic leukaemia stem cell transcriptomes anticipate disease morphology and outcomeDaniel H Wiseman, Syed M Baker, Arundhati V Dongre, et al.
Leukemia|January 15, 2025
Multi-omic analysis of chronic myelomonocytic leukemia monocytes reveals metabolic and immune dysregulation leading to altered macrophage polarizationHasse M Addinsell, Rachel Cant, Nathan J Hull, et al.
International Journal of Molecular Sciences|July 29, 2025
<i>BRCA2</i> Pre-mRNA Differential 5' Splicing: A Rescue of Functional Protein Properties from Pathogenic Gene Variants and a Lifeline for Fanconi Anemia D1 PatientsRoberto Paredes, Kiran Batta, Daniel H Wiseman, et al.
Journal of Inherited Metabolic Disease|June 22, 2012
Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experienceDaniel H Wiseman, Jean Mercer, Karen Tylee, et al.
British Journal of Haematology|March 11, 2014
Elevated plasma 2-hydroxyglutarate in acute myeloid leukaemia: association with the IDH1 SNP rs11554137 and severe renal impairmentDaniel H Wiseman, Helen F Small, Deepti P Wilks, et al.
Science Advances|January 2, 2026
Synergistic intragenic epigenetic deregulation by IDH2 and SRSF2 mutations causes mis-splicing of key transcriptional regulatorsAristeidis G Telonis, Robert F Stanley, Emmalee R Adelman, et al.
Iscience|August 4, 2023
Differentiation block in acute myeloid leukemia regulated by intronic sequences of <i>FTO</i>Francesco Camera, Isabel Romero-Camarero, Bradley H Revell, et al.
Blood Cancer Journal|July 12, 2024
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemiaYu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
BMC Cancer|October 29, 2021
Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activityMark S Williams, Naseer J Basma, Fabio M R Amaral, et al.
International Journal of Surgical Pathology|July 2, 2020
E-Cadherin Expression in Blastic Plasmacytoid Dendritic Cell Neoplasms: An Unrecognized Finding and Potential Diagnostic PitfallPatrick Shenjere, Richard Chasty, Anshuman Chaturvedi, et al.
Ebiomedicine|August 9, 2020
Chronic myelomonocytic leukaemia stem cell transcriptomes anticipate disease morphology and outcomeDaniel H Wiseman, Syed M Baker, Arundhati V Dongre, et al.
Leukemia|January 15, 2025
Multi-omic analysis of chronic myelomonocytic leukemia monocytes reveals metabolic and immune dysregulation leading to altered macrophage polarizationHasse M Addinsell, Rachel Cant, Nathan J Hull, et al.
International Journal of Molecular Sciences|July 29, 2025
<i>BRCA2</i> Pre-mRNA Differential 5' Splicing: A Rescue of Functional Protein Properties from Pathogenic Gene Variants and a Lifeline for Fanconi Anemia D1 PatientsRoberto Paredes, Kiran Batta, Daniel H Wiseman, et al.
Journal of Inherited Metabolic Disease|June 22, 2012
Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experienceDaniel H Wiseman, Jean Mercer, Karen Tylee, et al.
British Journal of Haematology|March 11, 2014
Elevated plasma 2-hydroxyglutarate in acute myeloid leukaemia: association with the IDH1 SNP rs11554137 and severe renal impairmentDaniel H Wiseman, Helen F Small, Deepti P Wilks, et al.
Science Advances|January 2, 2026
Synergistic intragenic epigenetic deregulation by IDH2 and SRSF2 mutations causes mis-splicing of key transcriptional regulatorsAristeidis G Telonis, Robert F Stanley, Emmalee R Adelman, et al.
Iscience|August 4, 2023
Differentiation block in acute myeloid leukemia regulated by intronic sequences of <i>FTO</i>Francesco Camera, Isabel Romero-Camarero, Bradley H Revell, et al.
Blood Cancer Journal|July 12, 2024
Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemiaYu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, et al.
Pageof 6